|1.||Pozzi, Ambra: 4 articles (10/2010 - 03/2008)|
|2.||Nyberg, Pia: 2 articles (11/2008 - 10/2005)|
|3.||Sudhakar, Akulapalli: 2 articles (11/2008 - 10/2005)|
|4.||Sugimoto, Hikaru: 2 articles (11/2008 - 10/2005)|
|5.||Kalluri, Raghu: 2 articles (11/2008 - 10/2005)|
|6.||Chen, Xiwu: 2 articles (08/2008 - 03/2008)|
|7.||Cosgrove, Dominic: 2 articles (03/2008 - 10/2005)|
|8.||Gardner, Humphrey: 2 articles (09/2005 - 03/2002)|
|9.||Wang, Can: 1 article (08/2012)|
|10.||Hou, Yanli: 1 article (08/2012)|
11/01/2008 - "Tumors implanted on integrin alpha1 deficient mice show no integrin alpha1 expression in the host-derived vascular endothelium, and thus arresten does not inhibit the tumor growth. "
10/01/2005 - "Consistent with this, alpha1(IV)NC1 elicited significant antiangiogenic effects and tumor growth inhibition in vivo but failed to do the same in alpha1 integrin receptor knockout mice. "
08/01/1998 - "Tumor-driven matrix invasion by infiltrating lymphocytes: involvement of the alpha1 integrin I-domain."
09/01/2008 - "Analysis of adhesive molecule expression revealed that B16F10 cells highly express CD44, integrin alpha1, alpha 4, alpha V, and beta1, and that Colon26 cells express CD44, integrin alpha2, alpha 5, alpha V, and beta1, suggesting that Gal-9 may inhibit the adhesion of tumor cells to vascular endothelium and the extracellular matrix (ECM) by binding to such adhesive molecules. "
02/29/2000 - "Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization."
09/01/2008 - "Here, we examined if alpha1beta1 integrin is required in the development and maintenance of the granulomatous structure during pulmonary infection using the alpha1 integrin knockout (alpha1-null) mouse. "
06/05/2005 - "Infection could be inhibited by collagen IV and antibodies specific for the beta1 and alpha1 integrin proteins, and fibroblasts from alpha1-integrin-/- mice were less efficiently infected than wild-type fibroblasts. "
|3.||Hepatocellular Carcinoma (Hepatoma)
10/01/1999 - "We investigated the expression of integrin alpha1, alpha2, alpha3, alpha6, beta1, and beta4 subunits on hepatoma cells by immunocytochemical and flow cytometric analysis. "
10/01/1999 - "Integrin alpha1, alpha2, alpha3, alpha6 and beta1 subunits were expressed at the marginal areas of hepatoma cells, while the integrin beta4 subunit was scarcely detected. "
12/01/1998 - "Alpha6 Integrin, beta1 integrin, and laminin binding protein showed notably increased expression in hepatocellular carcinoma, compared with non-cancerous liver tissue, although the alpha1 integrin did not show a significant change. "
12/01/1998 - "The expression of several laminin receptors, including alpha1 integrin, alpha6 integrin and its isoforms alpha6A and alpha6B, beta1 integrin and its isoforms beta1A and beta1B, and 32kD/67kDa laminin binding protein was examined in human hepatocellular carcinomas and non-cancerous liver tissues using the reverse transcription polymerase chain reaction. "
|4.||Graft vs Host Disease (Graft-Versus-Host Disease)
09/01/2000 - "In mice, monoclonal antibody (mAb) to the alpha1 integrin abrogate gastro-intestinal damage during graft-versus-host-disease (GVHD), suggesting anti alpha1 mAb as candidates for treatment in humans as well. "
04/01/2002 - "These models can be separated into several categories in which fibrosis is induced by external agents (vinyl chloride, bleomycin), by breeding of mutant strain combinations (integrin alpha 1 null mouse, MRL/lpr gamma R-/- mouse), and by transplantation of disparate immune cells (sclerodermatous graft versus host disease). "
|5.||Atherosclerotic Plaque (Atheroma)
|5.||Messenger RNA (mRNA)
|8.||Carrier Proteins (Binding Protein)
|9.||Calcium-Calmodulin-Dependent Protein Kinase Type 2
|10.||Transforming Growth Factor beta3 (TGF beta 3)
|1.||Transplantation (Transplant Recipients)